Gama limpiar

Expertos en desbridamiento

  • Desbridamiento eficaz y seguro
  • Fácil de usar y retirada en monobloque
  • Cambios indoloros y atraumáticos

picto_prepare_nb picto_clean picto_accelerate_nb picto_close_nb

 

 

 

 

Principio

El procedimiento de desbridamiento de una herida, puede ser difícil para los profesionales sanitarios (eliminar la fibrina sin dolor y evitar la hemorragia) y también desagradable y doloroso para el paciente (desbridamiento manual, sangrado…). Por esta razón, Urgo Medical ha desarrollado UrgoClean, una solución innovadora que desbrida las heridas con tejido fibrinoso y con exudado eficaz y eficientemente para mejorar la cicatrización.

 

Modo de acción

Cuando entra en contacto con el exudado, las fibras hidrodetersivas de poliacrilato gelifican, aumentan de volumen y se unen al residuo fibrinoso en el lecho de la herida, absorbiéndolo y drenándolo para permitir su retirada (desbridamiento autolítico). La creación de este gel en contacto con la herida mantiene el ambiente húmedo, que promueve la curación de las zonas desbridadas y retiene el exudado para impedir cualquier difusión lateral.

 

Video del modo de acción de UrgoClean

 

Indicaciones

Heridas exudativas con tejido esfacelado o fibrinoso (úlceras de pierna, úlceras por presión, úlceras de pie diabético, quemaduras, dermoabrasiones, heridas traumáticas, heridas post-operatorias…)

clean01

 

Contra-indicaciones

Mercurio orgánico (Mercryl Lauril ®, Dermachrome ®, Merfene ®) o hexamidina (Hexomédine ®) antisépticos y peróxido de hidrógeno (agua oxigenada).

 

Beneficios principales

  • Absorbe y drena el tejido esfacelado y bacterias
  • Retirada en una sola pieza
  • Proporciona cambios de apósito atraumáticos y sin dolor

 

Gama

range_clean03

 

Eidencia clínica

UrgoReviewTC23Feb_Web earth-study-march-2014  
Supporting evidence-based practice: a clinical review of TLC technology Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomised controlled trial (EARTH RCT)  
Download Download  

 

Management of chronic wounds with an innovative absorbent wound dressing

Meaume S. et al, journal of wound care vol 21 , no 7 , July 2012

  • Objective: To evaluate the efficacy and tolerability of an innovative absorbent wound dressing (UrgoClean; Laboratoires Urgo) in the local management of venous leg ulcers and pressure ulcers, during the sloughy stage of the healing process.
  • Method: A pilot, prospective, non-controlled open-label clinical trial held in 21 investigating centres. Adult patients, presenting with either a venous leg ulcer (VLU ) or a category III /IV pressure ulcer (PU ) with more than 50% of the surface area covered with sloughy tissue, a duration of less than 24 months, and no clinical signs of infection were included in the study. Patients were followed over a 6-week period with weekly visits, which included a physical examination, wound-area tracings and photographs by the investigating physician. Evaluations by the nursing staff and by the patients were made at each dressing change.
  • Results: Fifty patients with either a VLU (n=35) or a PU (n=15) were recruited. At baseline, mean wound surface area was 11.9 ± 11.3 cm2 and 12.5 ± 10.7 cm2, with a mean duration of 8.3 ± 6.4 months and 2.9 ± 3.0 months in the VLU and PU groups, respectively. Wounds in both groups were covered with more than 70% sloughy tissue, and the peri-lesional skin was considered to be healthy in 19 patients. By 6 weeks, mean wound surface area reduction in the VLU and PU groups was 23.7% and 29.2%, respectively, with full healing in 6 patients. All treated wounds were considered to be debrided by week 3 (< 40% slough for all wounds) and the median relative decrease of the sloughy tissue, at week 6, in the VLU and PU groups was 75% and 89%, respectively. Dressing acceptability was documented as being very good for both patients and nursing staff, particularly conformability and ease of use, with no residue left on the wound bed at dressing removal and the dressing also remained in one piece. Seven local adverse events were deemed to be potentially related to the trial dressing.
  • Conclusion: The results suggest that the dressing promoted the healing process of chronic wounds, showing itself to be a credible therapeutic alternative for the sloughy stage of the wound-healing process. It also demonstrated good tolerance and acceptability.
Última actualización : septiembre 18, 2017